About TypeZero Technologies
TypeZero Technologies is a company based in Charlottesville (United States) founded in 2013 was acquired by Dexcom in August 2018. TypeZero Technologies has raised $415 thousand across 2 funding rounds from investors including Dexcom and Center for Innovative Technology. TypeZero Technologies operates in a competitive market with competitors including Admetsys, Cellnovo, Pacific Diabetes Technologies, Ideal Medical Technologies and Animas, among others.
- Headquarter Charlottesville, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Typezero Technologies Llc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of TypeZero Technologies
TypeZero Technologies has successfully raised a total of $415K across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in TypeZero Technologies
TypeZero Technologies has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Dexcom and Center for Innovative Technology.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage VC firm funding companies in the US
|
Locked | Locked | Locked | |
|
Wearable glucose monitoring patches are provided for real-time data tracking.
|
Locked | Locked | Locked |
Investor details for TypeZero Technologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by TypeZero Technologies
Investment portfolio details for TypeZero Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - TypeZero Technologies
Detailed financials for TypeZero Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Typezero Technologies Comparisons
Peer comparison for TypeZero Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of TypeZero Technologies
TypeZero Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Admetsys, Cellnovo, Pacific Diabetes Technologies, Ideal Medical Technologies and Animas, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of a closed-loop system for insulin and glucose delivery
|
|
| Locked | Locked | Locked |
Offers online slot gaming with bonuses, promotions, and secure interface.
|
|
| Locked | Locked | Locked |
Electronic diabetes management device for glucose sensing and hormone delivery
|
|
| Locked | Locked | Locked |
An AI-based artificial pancreas system is developed for ICU patients.
|
|
| Locked | Locked | Locked |
Device for continuous glucose monitoring with manual insulin administration
|
Detailed competitors of TypeZero Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Typezero Technologies
Complete news archive for TypeZero Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about TypeZero Technologies
TypeZero Technologies was founded in 2013 and raised its 1st funding round 2 years after it was founded.
TypeZero Technologies is headquartered in Charlottesville, United States. It is registered at Charlottesville, Virginia, United States.
TypeZero Technologies is a funded company, having raised a total of $415K across 2 funding rounds to date.
Typezero products help in diabetes management by providing smartphone based solution that controls insulin delivery, reduce a patients average blood sugar level while simultaneously reducing a patients risk of hypoglycemic events. Their inControl Advice is an app-based solution that provides real-time recommendations for meals, basal rates, insulin bolus calculations and exercise decisions. It also has a cloud based analytics and support system to provide real-time monitoring and notifications and analytics. The solutions will be used in a large scale NIH sponsored (12.7 Million) clinical study by University of Virginia.
TypeZero Technologies's top competitors include Admetsys, Ideal Medical Technologies and Pacific Diabetes Technologies.
TypeZero Technologies has 2 investors. Key investors include Dexcom, and Center for Innovative Technology.